PROVIDER PROFILE · NPI 1275567000

Julie RamosMD

PRACTICEJULIE J. RAMOS, MD PASee all providers at this practice →

CardiologyOcala, FLI

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,779

Unique beneficiaries

—

Total services

7,323

Distinct HCPCS

Medicare payment

$628K

Peer benchmark

Total Medicare services vs. 1,499 Cardiology providers in FL — top quintile (cohort median 2,540).

PRESCRIBING · PART D · 2024

Total Rx claims

1,116

Beneficiaries

—

Total drug cost

$490K

Distinct drugs

Brand share

41.8%

Top prescribed drugs

Sacubitril/Valsartan150 claims

Apixaban124 claims

Metoprolol Succinate98 claims

Furosemide82 claims

Amlodipine Besylate59 claims

QUALITY · MIPS · 2024

Final MIPS score

75.0

Quality

20.0

Cost

71.2

Improvement activities

0.0

Promoting interop.

0.0

Payment adjustment

0.00%

Individual

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

Total received

$1K

Payment records

By payment type

Food and Beverage$1K

FACILITY AFFILIATIONS

Hospital & Facility Affiliations (2)

CCN 100062

Hospital

CCN 100212

Hospital

REFERRAL NETWORK

Where Julie Ramos's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 0 inbound referrers · 3 outbound destinations.

Receives referrals from

Inbound — who sends patients here

No inbound pairs above the suppression threshold.

Refers patients to

Outbound — where patients go next

Physician	Patients	Visits
MONTEFIORE MEDICAL CENTER	38	141
Quest Diagnostics Incorporated Clinical Laboratory · Clifton, NJ	15	40
Sana Bloch Psychiatry & Neurology · Bronx, NY	14	28

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history